Rare diseases
Investigational molecules
Locations
296 conditions with trials, the busiest first
591 trials across Europe, recruiting first
CzechiaA study of allogeneic adipose-derived mesenchymal stem cells for the treatment of chronic active antibody-mediated rejection in kidney transplant recipients
DenmarkA long-term safety study of KYV-101 in patients previously treated for lupus nephritis, systemic sclerosis, myasthenia gravis, rheumatoid arthritis, or stiff person syndrome
GermanyStudy of the effect of empagliflozin on protein levels in the urine for patients with type 2 diabetes and kidney disease.
FranceEffect of levothyroxine on kidney function in patients at risk of hypothyroidism after partial thyroid surgery
DenmarkComparing the effectiveness of 7 days versus 14 days of ciprofloxacin or ceftriaxone for treating kidney infection in kidney transplant recipients
SpainA study to evaluate the effectiveness of R2R01 in preventing acute kidney injury in patients at high risk following heart surgery.
GermanyA study to evaluate the safety of ADX-038 in patients with complement-mediated kidney disease
ItalyA study to evaluate the effectiveness and safety of ursodeoxycholic acid in patients with hepatorenal polycystic diseases.
SpainObinutuzumab treatment for adults with frequently relapsing idiopathic nephrotic syndrome who are dependent on rituximab
ItalyA study to evaluate the effect of orforglipron on cardiovascular health in adults with atherosclerotic cardiovascular disease and/or chronic kidney disease
AustriaPhase 1/2 Evaluation of Zilovertamab Vedotin in PD-1/L1 Refractory Locally Advanced or Metastatic Urothelial Carcinoma
DenmarkThe therapies tested most often in Renal and urinary disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
